Perimeter Medical Imaging
About Perimeter Medical Imaging
Perimeter Medical Imaging AI, founded in 2013 and headquartered in Toronto, Canada, with U.S. offices in Dallas, Texas, is a medical technology innovator transforming cancer surgery. The company specializes in high-resolution, real-time imaging systems that provide surgeons with cellular-level visualization of excised tissues in the operating room. Their flagship product, the FDA-cleared Perimeter S-Series OCT, empowers surgeons to assess tissue margins during procedures, reducing the likelihood of re-operations. In development is the B-Series OCT with ImgAssist AI, a groundbreaking tool combining optical coherence tomography with artificial intelligence to enhance intraoperative decision-making. Through innovative technologies and pivotal clinical trials, Perimeter aims to improve surgical precision, enhance patient outcomes, and address unmet medical needs in oncology care.
Chamath's Breast Cancer Company Wins FDA Approval
Perimeter Medical Imaging (TSXV: PINK) has received premarket approval from the United States Food and Drug Administration for their AI enabled imaging device.
Chamath Palihapitiya Is Backing Perimeter Medical Imaging AI
Perimeter Medical Imaging AI (TSXV: PINK) has raised $9.8M CAD in a new financing round, which was led by Chamath Palihapitiya's family office Social Capital.
